TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from Southern Brazil
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from Southern Brazil
Authors
Keywords
-
Journal
LUPUS
Volume 21, Issue 3, Pages 302-309
Publisher
SAGE Publications
Online
2011-11-08
DOI
10.1177/0961203311425522
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytomegalovirus as a Trigger for Systemic Lupus Erythematosus
- (2016) Arnaldo E. Pérez-Mercado et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study
- (2011) Aya Kawasaki et al. ARTHRITIS RESEARCH & THERAPY
- The role of mannose-binding lectin gene polymorphisms in susceptibility to HIV-1 infection in Southern Brazilian patients
- (2010) Gabriela Kniphoff da Silva et al. AIDS
- Epstein-Barr virus promotes interferon-α production by plasmacytoid dendritic cells
- (2010) Timothy E. Quan et al. ARTHRITIS AND RHEUMATISM
- Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
- (2010) A. Komatsuda et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Genetic modulation of TLR8 response following bacterial phagocytosis
- (2010) Michael P. Gantier et al. HUMAN MUTATION
- Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors
- (2010) Jérôme Cros et al. IMMUNITY
- Parvovirus B19-associated Systemic Lupus Erythematosus: Clinical Mimicry or Autoimmune Induction?
- (2010) M. T. HESSION et al. JOURNAL OF RHEUMATOLOGY
- Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus
- (2010) S. Iskra et al. JOURNAL OF VIROLOGY
- Clinical and Molecular Evidence for Association of SLE with parvovirus B19
- (2010) M. Pavlovic et al. LUPUS
- Epstein Barr virus inhibits the stimulatory effect of TLR7/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes
- (2010) Vahid Younesi et al. MICROBIOLOGY AND IMMUNOLOGY
- Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus
- (2010) N. Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Infection aiguë à cytomégalovirus révélatrice d’un lupus érythémateux systémique
- (2010) W. Hachfi et al. REVUE DE MEDECINE INTERNE
- A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression
- (2009) Djin-Ye Oh et al. AIDS
- Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel
- (2009) Ney P.C. Santos et al. HUMAN MUTATION
- Increase in NF- B Binding Affinity of the Variant C Allele of the Toll-Like Receptor 9 -1237T/C Polymorphism Is Associated with Helicobacter pylori-Induced Gastric Disease
- (2009) M. T. H. Ng et al. INFECTION AND IMMUNITY
- The DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
- (2008) Tobias Haas et al. IMMUNITY
- A Functional Toll‐Like Receptor 8 Variant Is Associated with HIV Disease Restriction
- (2008) D.‐Y. Oh et al. JOURNAL OF INFECTIOUS DISEASES
- Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders
- (2008) S Moller-Larsen et al. THORAX
- Genetic Association and Expression Studies Indicate a Role of Toll-Like Receptor 8 in Pulmonary Tuberculosis
- (2008) Sonia Davila et al. PLoS Genetics
- Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9
- (2007) Stefan Bauer et al. IMMUNOBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started